Brown Brothers Harriman & Co. Decreases Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Brown Brothers Harriman & Co. lowered its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 34.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 2,638 shares of the company’s stock after selling 1,377 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in Ryan Specialty were worth $169,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Rakuten Securities Inc. purchased a new position in Ryan Specialty in the fourth quarter valued at approximately $27,000. Principal Securities Inc. boosted its holdings in shares of Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company’s stock valued at $43,000 after buying an additional 415 shares in the last quarter. Quarry LP grew its position in shares of Ryan Specialty by 109.3% in the 3rd quarter. Quarry LP now owns 808 shares of the company’s stock valued at $54,000 after buying an additional 422 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new stake in Ryan Specialty during the 4th quarter worth $54,000. Finally, R Squared Ltd purchased a new stake in Ryan Specialty in the fourth quarter valued at $92,000. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Trading Up 1.4 %

NYSE RYAN opened at $73.96 on Tuesday. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market capitalization of $19.37 billion, a P/E ratio of 107.18, a P/E/G ratio of 1.19 and a beta of 0.71. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $75.97. The firm has a 50-day moving average price of $68.89 and a 200 day moving average price of $68.39.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Equities research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, March 4th. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.65%. Ryan Specialty’s dividend payout ratio is 69.57%.

Insider Activity

In related news, Director Nicholas Dominic Cortezi sold 29,466 shares of the firm’s stock in a transaction that occurred on Monday, January 13th. The stock was sold at an average price of $65.06, for a total value of $1,917,057.96. Following the completion of the transaction, the director now directly owns 45,409 shares of the company’s stock, valued at $2,954,309.54. This trade represents a 39.35 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. Insiders sold 241,360 shares of company stock worth $16,006,428 in the last 90 days. 11.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have recently commented on RYAN. UBS Group lifted their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Royal Bank of Canada decreased their price objective on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a report on Friday, February 21st. Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a report on Friday, February 21st. Wells Fargo & Company upped their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a research report on Friday, February 21st. Finally, Morgan Stanley initiated coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price objective on the stock. One research analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $75.27.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.